Aspirin attenuates insulin resistance in muscle of diet-induced obese rats by inhibiting inducible nitric oxide synthase production and S-nitrosylation of Irβ/irs-1 and akt

FAPESP – FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULOCNPQ – CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICOAim/hypothesis: High-dose aspirin treatment improves fasting and postprandial hyperglycaemia in patients with type 2 diabetes, as well as in animal models of insulin resistance associated with obesity and sepsis. In this study, we investigated the effects of aspirin treatment on inducible nitric oxide synthase (iNOS)-mediated insulin resistance and on S-nitrosylation of insulin receptor (IR)-β, IRS-1 and protein kinase B (Akt) in the muscle of diet-induced obese rats and also in iNos (also known as Nos2)-/- mice on high fat diet. Methods: Aspirin (120 mg kg-1 day-1 for 2 days) or iNOS inhibitor (L-NIL; 80 mg/kg body weight) were administered to diet-induced obese rats or mice and iNOS production and insulin signalling were investigated. S-nitrosylation of IRβ/IRS-1 and Akt was investigated using the biotin switch method. Results: iNOS protein levels increased in the muscle of diet-induced obese rats, associated with an increase in S-nitrosylation of IRβ, IRS-1 and Akt. These alterations were reversed by aspirin treatment, in parallel with an improvement in insulin signalling and sensitivity, as measured by insulin tolerance test and glucose clamp. Conversely, while aspirin reversed the increased phosphorylation of IκB kinase β and c-Jun amino-terminal kinase, as well as IRS-1 serine phosphorylation in diet-induced obese rats and iNos -/- mice on high-fat diet, these alterations were not associated with the improvement of insulin action induced by this drug. Conclusions/interpretation: Our data demonstrate that aspirin treatment not only reduces iNOS protein levels, but also S-nitrosylation of IRβ, IRS-1 and Akt. These changes are associated with improved insulin resistance and signalling, suggesting a novel mechanism of insulin sensitisation evoked by aspirin treatment. © 2009 Springer-Verlag.High-dose aspirin treatment improves fasting and postprandial hyperglycaemia in patients with type 2 diabetes, as well as in animal models of insulin resistance associated with obesity and sepsis. In this study, we investigated the effects of aspirin treatment on inducible nitric oxide synthase (iNOS)-mediated insulin resistance and on S-nitrosylation of insulin receptor (IR)-β, IRS-1 and protein kinase B (Akt) in the muscle of diet-induced obese rats and also in iNos (also known as Nos2)-/- mice on high fat diet. Methods: Aspirin (120 mg kg-1 day-1 for 2 days) or iNOS inhibitor (L-NIL; 80 mg/kg body weight) were administered to diet-induced obese rats or mice and iNOS production and insulin signalling were investigated. S-nitrosylation of IRβ/IRS-1 and Akt was investigated using the biotin switch method. Results: iNOS protein levels increased in the muscle of diet-induced obese rats, associated with an increase in S-nitrosylation of IRβ, IRS-1 and Akt. These alterations were reversed by aspirin treatment, in parallel with an improvement in insulin signalling and sensitivity, as measured by insulin tolerance test and glucose clamp. Conversely, while aspirin reversed the increased phosphorylation of IκB kinase β and c-Jun amino-terminal kinase, as well as IRS-1 serine phosphorylation in diet-induced obese rats and iNos -/- mice on high-fat diet, these alterations were not associated with the improvement of insulin action induced by this drug. Conclusions/interpretation: Our data demonstrate that aspirin treatment not only reduces iNOS protein levels, but also S-nitrosylation of IRβ, IRS-1 and Akt. These changes are associated with improved insulin resistance and signalling, suggesting a novel mechanism of insulin sensitisation evoked by aspirin treatment521124252434FAPESP – FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULOCNPQ – CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICOFAPESP – FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULOCNPQ – CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICOSethi, J.K., Hotamisligil, G.S., The role of TNF alpha in adipocyte metabolism (1999) Semin Cell Dev Biol, 10, pp. 19-29. , 10355025 10.1006/scdb.1998.0273 1:CAS:528:DyaK1MXjsFGitbg%3DHirosumi, J., Tuncman, G., Chang, L., Gorgun, C.Z., Uysal, K.T., Maeda, K., Karin, M., Hotamisligil, G.S., A central, role for JNK in obesity and insulin resistance (2002) Nature, 420 (6913), pp. 333-336. , DOI 10.1038/nature01137Perreault, M., Marette, A., Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle (2001) Nature Medicine, 7 (10), pp. 1138-1143. , DOI 10.1038/nm1001-1138Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., Shoelson, S.E., Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkβ (2001) Science, 293 (5535), pp. 1673-1677. , DOI 10.1126/science.1061620Barreiro, G.C., Prattali, R.R., Caliseo, C.T., Fugiwara, F.Y., Ueno, M., Prada, P.O., Velloso, L.A., Carvalheira, J.B.C., Aspirin inhibits serine phosphorylation of IRS-1 in muscle and adipose tissue of septic rats (2004) Biochemical and Biophysical Research Communications, 320 (3), pp. 992-997. , DOI 10.1016/j.bbrc.2004.06.048, PII S0006291X04013282Hundal, R.S., Petersen, K.F., Mayerson, A.B., Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes (2002) J Clin Invest, 109, pp. 1321-1326. , 12021247 1:CAS:528:DC%2BD38XjvFCls74%3DKim, J.K., Kim, Y.J., Fillmore, J.J., Prevention of fat-induced insulin resistance by salicylate (2001) J Clin Invest, 108, pp. 437-446. , 11489937 1:CAS:528:DC%2BD3MXlvVGltLk%3DGao, Z., Zuberi, A., Quon, M.J., Dong, Z., Ye, J., Aspirin Inhibits Serine Phosphorylation of Insulin Receptor Substrate 1 in Tumor Necrosis Factor-treated Cells through Targeting Multiple Serine Kinases (2003) Journal of Biological Chemistry, 278 (27), pp. 24944-24950. , DOI 10.1074/jbc.M300423200Carvalho-Filho, M.A., Ueno, M., Hirabara, S.M., Seabra, A.B., Carvalheira, J.B.C., De Oliveira, M.G., Velloso, L.A., Saad, M.J.A., S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: A novel mechanism of insulin resistance (2005) Diabetes, 54 (4), pp. 959-967. , DOI 10.2337/diabetes.54.4.959Carvalho-Filho, M.A., Ueno, M., Carvalheira, J.B.C., Velloso, L.A., Saad, M.J.A., Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRβ/IRS-1 and Akt and insulin resistance in muscle of mice (2006) American Journal of Physiology - Endocrinology and Metabolism, 291 (3), pp. E476-E482. , http://ajpendo.physiology.org/cgi/reprint/291/3/E476, DOI 10.1152/ajpendo.00422.2005Cieslik, K., Zhu, Y., Wu, K.K., Salicylate suppresses macrophage nitric-oxide synthase-2 and cyclo-oxygenase-2 expression by inhibiting CCAAT/enhancer-binding protein-β binding via a common signaling pathway (2002) Journal of Biological Chemistry, 277 (51), pp. 49304-49310. , DOI 10.1074/jbc.M205030200Katsuyama, K., Shichiri, M., Kato, H., Imai, T., Marumo, F., Hirata, Y., Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells (1999) Endocrinology, 140, pp. 2183-2190. , 10218970 10.1210/en.140.5.2183 1:CAS:528:DyaK1MXislSntrc%3DWang, Z., Brecher, P., Salicylate inhibition of extracellular signal-regulated kinases and inducible nitric oxide synthase (1999) Hypertension, 34, pp. 1259-1264. , 10601128 1:CAS:528:DC%2BD3cXivFCktA%3D%3DSugita, H., Fujimoto, M., Yasukawa, T., Shimizu, N., Sugita, M., Yasuhara, S., Martyn, J.A.J., Kaneki, M., Inducible nitric-oxide synthase and NO donor induce insulin receptor substrate-1 degradation in skeletal muscle cells (2005) Journal of Biological Chemistry, 280 (14), pp. 14203-14211. , DOI 10.1074/jbc.M411226200Bonora, E., Moghetti, P., Zancanaro, C., Estimates of in vivo insulin action in man: Comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies (1989) J Clin Endocrinol Metab, 68, pp. 374-378. , 2645308 10.1210/jcem-68-2-374 1:STN:280:DyaL1M7jvFOntw%3D%3DPrada, P.O., Zecchin, H.G., Gasparetti, A.L., Torsoni, M.A., Ueno, M., Hirata, A.E., Corezola Do Amaral, M.E., Saad, M.J.A., Western diet modulates insulin signaling, c-jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion (2005) Endocrinology, 146 (3), pp. 1576-1587. , DOI 10.1210/en.2004-0767Saad, M.J., Araki, E., Miralpeix, M., Rothenberg, P.L., White, M.F., Kahn, C.R., Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance (1992) J Clin Invest, 90, pp. 1839-1849. , 1331176 10.1172/JCI116060 1:CAS:528:DyaK3sXjtlarsA%3D%3DTremblay, F., Lavigne, C., Jacques, H., Marette, A., Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (zeta/lambda) activities (2001) Diabetes, 50, pp. 1901-1910. , 11473054 10.2337/diabetes.50.8.1901 1:CAS:528:DC%2BD3MXlslKmsrk%3DJaffrey, S.R., Snyder, S.H., The biotin switch method for the detection of S-nitrosylated proteins (2001) Sci STKE 2001: PL1Martinez-Ruiz, A., Lamas, S., Detection and proteomic identification of S-nitrosylated proteins in endothelial cells (2004) Archives of Biochemistry and Biophysics, 423 (1), pp. 192-199. , DOI 10.1016/j.abb.2003.12.006Lynge, J., Juel, C., Hellsten, Y., Extracellular formation and uptake of adenosine during skeletal muscle contraction in the rat: Role of adenosine transports (2001) Journal of Physiology, 537 (2), pp. 597-605. , DOI 10.1111/j.1469-7793.2001.00597.xBradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding (1976) Anal Biochem, 72, pp. 248-254. , 942051 10.1016/0003-2697(76)90527-3 1:CAS:528:DyaE28XksVehtrY%3DPollock, J.S., Forstermann, U., Mitchell, J.A., Warner, T.D., Schmidt, H.H.H.W., Nakane, M., Murad, F., Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells (1991) Proceedings of the National Academy of Sciences of the United States of America, 88 (23), pp. 10480-10484Cai, D., Yuan, M., Frantz, D.F., Melendez, P.A., Hansen, L., Lee, J., Shoelson, S.E., Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB (2005) Nature Medicine, 11 (2), pp. 183-190. , DOI 10.1038/nm1166Rohl, M., Pasparakis, M., Baudler, S., Conditional disruption of IkappaB kinase 2 fails to prevent obesity-induced insulin resistance (2004) J Clin Invest, 113, pp. 474-481. , 14755344Jiang, G., Dallas-Yang, Q., Liu, F., Moller, D.E., Zhang, B.B., Salicylic acid reverses phorbol 12-myristate-13-acetate (PMA)- and tumor necrosis factor α (TNFα)-induced insulin receptor substrate 1 (IRS1) serine 307 phosphorylation and insulin resistance in human embryonic kidney 293 (HEK293) cells (2003) Journal of Biological Chemistry, 278 (1), pp. 180-186. , DOI 10.1074/jbc.M205565200Prattali, R.R., Barreiro, G.C., Caliseo, C.T., Fugiwara, F.Y., Ueno, M., Prada, P.O., Velloso, L.A., Carvalheira, J.B.C., Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in growth hormone treated animals (2005) FEBS Letters, 579 (14), pp. 3152-3158. , DOI 10.1016/j.febslet.2005.04.075, PII S0014579305005648Fujimoto, M., Shimizu, N., Kunii, K., Martyn, J.A.J., Ueki, K., Kaneki, M., A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice (2005) Diabetes, 54 (5), pp. 1340-1348. , DOI 10.2337/diabetes.54.5.1340Taylor, B.S., Geller, D.A., Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene (2000) Shock, 13, pp. 413-424. , 10847627 1:STN:280:DC%2BD3M%2FhvFyrug%3D%3DYasukawa, T., Tokunaga, E., Ota, H., Sugita, H., Martyn, J.A.J., Kaneki, M., S-nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance (2005) Journal of Biological Chemistry, 280 (9), pp. 7511-7518. , DOI 10.1074/jbc.M411871200Dallaire, P., Bellmann, K., Laplante, M., Obese mice lacking inducible nitric oxide synthase are sensitized to the metabolic actions of peroxisome proliferator-activated receptor-gamma agonism (2008) Diabetes, 57, pp. 1999-2011. , 18458147 10.2337/db08-0540 1:CAS:528:DC%2BD1cXps1Oisr0%3DFleischman, A., Shoelson, S.E., Bernier, R., Goldfine, A.B., Salsalate improves glycemia and inflammatory parameters in obese young adults (2008) Diabetes Care, 31 (2), pp. 289-294. , http://care.diabetesjournals.org/cgi/reprint/31/2/289, DOI 10.2337/dc07-1338Goldfine, A.B., Silver, R., Aldhahi, W., Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes (2008) Clin Transl Sci, 1, pp. 36-43. , 19337387 10.1111/j.1752-8062.2008.00026.x 1:CAS:528:DC%2BD1cXpt1Gnsbo%3